https://www.selleckchem.com/products/agk2.html 001), but analysis of similarities (ANOSIM) failed to provide evidence for microbial dissimilarity between pre- and post-chill samples (p=0.001, R=0.443). Various ML models were trained using post-chill samples to predict if a sample contained Salmonella based on the samples' microbiota pre-enrichment. The optimal model was a Random Forest-based model with a performance as follows accuracy (88%), sensitivity (85%), specificity (90%). While the algorithms described in this paper are prototypes, these risk-based algorithms demonstrate the potential and need for further studies to provide insight alongside diagnostic tests. Combining risk-based information with diagnostic tools can help poultry processors make informed decisions to help identify and prevent the spread of Salmonella . These data add to the growing body of literature exploring novel ways to utilize microbiome data for predictive food safety. Programmed death-1 ligand (PD-L1) contributes to tumor immunosuppression and is upregulated in aggressive meningiomas. We performed a phase II study of nivolumab, a programmed death-1 (PD-1) blocking antibody among patients with grade ≥2 meningioma that recurred after surgery and radiation therapy. Twenty-five patients received nivolumab (240mg biweekly) until progression, voluntary withdrawal, unacceptable toxicity, or death. Tumor mutational burden (TMB) and quantification of tumor infiltrating lymphocytes (TIL) were evaluated as potential immunocorrelative biomarkers. Change in neurologic function was prospectively assessed using the Neurologic Assessment in Neuro-Oncology (NANO) scale. Enrolled patients had multiple recurrences including ≥3 prior surgeries and ≥2 prior courses of radiation in 60% and 72%, respectively. Nivolumab was well tolerated with no unexpected AEs. PFS-6 was 42.4% (95% CI 22.8, 60.7) and the median OS was 30.9 months (95% CI 17.6, NA). One patient achieved radiographic response (ongoing at 4.5